In an aerial view, brand new Subaru cars sit in a storage lot at Auto Warehouse Co. on March 4, 2025 in Richmond, California. Justin Sullivan | Getty Images The White House on Wednesday announced a one-month North American tariff exemption for automakers after President Donald Trump spoke a day earlier with heads of General […]
Trump grants automakers one-month exemption from tariffs Read More »
A version of this article first appeared in CNBC’s Inside Wealth newsletter with Robert Frank, a weekly guide to the high net worth investor and consumer. Sign up to receive future editions, straight to your inbox. While family offices pride themselves on investing for the long term, this week’s tariff volatility and confusion around government
Family offices rattled by market swings and tariffs Read More »
Macy’s delivered another quarter of mixed results on Thursday as investors wait and see how quickly CEO Tony Spring can pull off a turnaround of the business with yet another activist investor looking to take the chain private. Across the business, which includes the Macy’s banner, Bloomingdale’s and Blue Mercury, comparable sales during the all-important
Macy’s turnaround starts to take shape, but ailing stores weigh on quarterly results Read More »
Residential apartment buildings in the Brooklyn borough of New York, US, on Wednesday, July 17, 2024. Yuki Iwamura | Bloomberg | Getty Images New apartment construction hit a record high last year, but all that new supply is apparently not enough to cool the competition in the market. Getting a rental is actually becoming even
These are the most competitive rental markets in the U.S. Read More »
Novo Nordisk’s Wegovy weight loss drug has seen a meteoric rise in popularity. Nurphoto | Getty Images Novo Nordisk on Wednesday said it will offer its weight loss drug Wegovy for less than half of its usual price per month through a new direct-to-consumer online pharmacy. The cash-pay offering is available to millions of patients
The Amgen logo is displayed outside Amgen headquarters in Thousand Oaks, California, on May 17, 2023. Mario Tama | Getty Images Amgen on Wednesday said it has started two critical late-stage trials for its experimental weight loss injection MariTide, another step in its bid to enter the booming obesity drug market. “We’re delighted to share
Amgen starts two critical late-stage trials for weight loss drug MariTide Read More »
National Hockey League Commissioner Gary Bettman said Wednesday that the league could be affected by the current tensions between the U.S. and Canada. Bettman said 25% of the league’s revenue comes from its Canadian clubs. Though he said the Canadian teams perform well, Bettman added that there could be ramifications for the league depending on
NHL commissioner says league could be affected by U.S.-Canada tariffs Read More »
Abercrombie & Fitch‘s growth story is starting to slow down. The apparel retailer issued weaker-than-expected guidance for its current quarter and fiscal 2025, and said it expects its sales will grow more slowly than Wall Street anticipated. Abercrombie is expecting sales to rise between 3% and 5% in fiscal 2025, well below estimates of 6.8%
Abercrombie & Fitch shares fall after star retailer posts weak guidance for year ahead Read More »
Kenvue settled its proxy fight with activist Starboard Value, adding three new directors to its board. Starboard’s Jeff Smith will join the board of the Johnson & Johnson spinoff, along with Sarah Hofstetter, president of Profitero, an eCommerce performance analytics platform, and Erica Mann, former head of pharmaceutical company Bayer’s consumer health division. “Sarah’s brand
Kenvue settles proxy fight with activist Starboard, adding three directors to its board Read More »
Foot Locker said Wednesday it expects another year of deep discounts in the sneaker industry as its largest brand partner Nike continues its reset and relies on markdowns to clear through stale inventory. The footwear giant delivered mix results for its holiday quarter, beating Wall Street’s expectations on earnings but falling short on sales. In
